Toucan Capital is a leading venture capital firm based in Bethesda, United States. With a focus on seed and early-stage life science and advanced technology investments, the firm has a preference for startups that are 4-5 years old. Some notable portfolio companies include Intrapace, Pepgen Corporation, and Q Therapeutics, with a particular emphasis on the medical and clinical trials industries. Toucan Capital typically invests in rounds with 4-5 participants and has been known to co-invest with other firms like Silicon Alley Venture Partners and Sevin Rosen Funds. The firm has a track record of successful exits, with the highest number of exits occurring in 2009. Overall, Toucan Capital is recognized for its active involvement in the mid-Atlantic region, where it has played a significant role in supporting the life science and advanced technology sectors.